IQIRVO
As listed in the register: IQIRVO
80 mg · tablet
- Prescription only
- Digestion, stomach, diabetes and nutrition
- Active substance
- Elafibranor
- Made by
- Ipsen Biopharmaceuticals Canada Inc
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (IQIRVO). It describes the substance, not this exact product.
Elafibranor and its main active metabolite GFT1007 are peroxisome proliferator-activated receptor (PPAR) agonists, both of which activate PPAR-alpha, PPAR-gamma, and PPAR-delta in vitro.
However, the mechanism by which elafibranor exerts its therapeutic effects in patients with PBC is not well understood.
Elafibranor is extensively metabolized to form a major active metabolite, GFT1007.
Effect of Food When administered with a high-fat and high-calorie meal, T max was delayed by 30 minutes for elafibranor and by 1-hour for GFT1007 compared to in fasted conditions.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-08-11
Safety of the active substance
From the US prescribing label for the same active substance (IQIRVO). It describes the substance, not this exact product.
The most common adverse reaction leading to treatment discontinuation was increased CPK (4%).
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
Spain1 matching products
Netherlands1 matching products
Details
| Made by | Ipsen Biopharmaceuticals Canada Inc |
|---|---|
| Active substance | Elafibranor |
| Used in | Digestion, stomach, diabetes and nutrition |
| Strength | 80 mg |
| Form | tablet |
| Classification | A05AX06 · Digestion, stomach, diabetes and nutrition |
| Route | oral |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02557010 |
| DPD drug code | 106038 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.